0001209191-23-049346.txt : 20230913
0001209191-23-049346.hdr.sgml : 20230913
20230913185533
ACCESSION NUMBER: 0001209191-23-049346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230913
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deignan Charles A.
CENTRAL INDEX KEY: 0001664690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 231253745
MAIL ADDRESS:
STREET 1: C/O CLEARSIDE BIOMEDICAL, INC.
STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-13
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001664690
Deignan Charles A.
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-09-13
4
M
0
34090
0.40
A
397562
D
Employee Stock Option (right to buy)
0.40
2023-09-13
4
M
0
34090
0.00
D
2023-11-24
Common Stock
34090
0
D
Fully vested and exercisable.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-09-13